NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of HealthEquity, ...

HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.

In the last three months, 4 analysts have published ratings on HealthEquity (NASDAQ ... and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that ...

Such investors are advised to contact Danielle Peyton at ... or 646-581-9980, ext. 7980. The investigation concerns whether HealthEquity and certain of its officers and/or directors have engaged ...

11 New Issues of Our Premium Readership Newsletter ... HQY) in its Q4 2024 investor letter: “HealthEquity, Inc. (NASDAQ:HQY) was another top contributor. HealthEquity is the largest U.S ...

This unexpected expense has raised concerns among investors and analysts about the potential impact on future margins and profitability. HealthEquity maintains a strong position in the HSA market, ...

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to ...

Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised ...